期刊文献+

CT引导下^125I放射性粒子组织间植入治疗纵隔转移性淋巴结 被引量:17

CT-guided interstitial brachytherapy for metastatic carcinoma of lymph nodes in mediastinum
原文传递
导出
摘要 目的 探讨CT引导下经皮穿刺^125I放射性粒子植入治疗纵隔转移性淋巴结的技术方法、安全性及临床价值.方法 应用^125I放射性粒子组织间种植治疗纵隔淋巴结转移患者8例,所有患者采用前路进针途径穿刺,按照病灶与体表穿刺点的位置设定CT机架的角度,采用多方位重组技术及平头针芯捻压分离主动脉、上腔静脉间隙进针法植入^125I放射性粒子.疗效评价采用术后治疗计划系统(TPS),验证放射性粒子种植后剂量分布,观察治疗后患者局部压迫症状(气短、咳嗽、吞咽困难等)的改善情况及粒子植入术后2个月靶淋巴结的局部反应,并记录并发症情况.结果 植入术后粒子覆盖率为(93.5 ±1.5)%.术后2个月复查,其中完全缓解(CR)3例,部分缓解(PR)4例,病灶稳定(SD)1例.5例气短、4例咳嗽和吞咽困难等局部压迫症状均有不同程度减轻,未出现头颈部及上肢水肿.术后无严重并发症发生;无大血管、气管、食管损伤,1例出现少量气胸.结论 CT引导下经皮穿刺组织间放射性粒子植入治疗纵隔4R区肿瘤转移性淋巴结,疗效肯定、安全可靠,为常规治疗局部压迫症状较严重的复杂部位淋巴结转移,提供了一种新的微创治疗方法. Objective To investigate the technique,safety and clinical value of CT-guided percutaneous interstitial brachytherapy for metastatic carcinoma of lymph nodes in mediastinum.Methods Eight patients with metastatic carcinoma of lymph nodes in mediastinum were treated by CT-guided interstitial implant of radioactive seeds in our department.Anterior approach were performed on all cases,125I radioactive seeds were implanted by setting CT Gantry at an oblique angle,three-dimensional reconstruction with SCT and separation the narrow gap between aortic arch and superior vena cava with fiatscalp core.Dose distributions were checked by TPS after operation.The improvement in clinical symptoms and lymph node sizes were documented in order to investigate the therapeutic effects.Results The particle coverage rate was 93.5% ± 1.5%.According to the CT scans two months later,3 patients ( 37.5% ) had complete ablation,4 (50%) partial ablation,and 1 ( 12.5% ) stable disease.Overall response rate (CR + PR) for this group of patients was 87.5%.The symptoms of all patients including shortness of breath (5 patients),cough (4 patients),dysphagia (4 patients) showed varying degree of improvement.No edema of head-and-neck and upper extremity was observed.There was no major vascular,tracheal and esophageal injury.A small amount of pneumothorax was observed in one patient.Conclusions CT-guided percutaneous interstitial brachytherapy,a minimally invasive procedure associated with favorable therapeutic results,is a promising technique for treatment of metastatic carcinoma of lymph nodes with local pressure symptoms which may not respond to conventional therapy.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2011年第12期1190-1193,共4页 Chinese Journal of Radiology
关键词 近距离放射疗法 淋巴结转移肿瘤 组织间照射 种植 Brachytherapy Carcinoma metastatic lymph node Interstital irradiation Implantation
  • 相关文献

参考文献6

  • 1张福君,吴沛宏,顾仰葵,赵明,张亮,谭志斌,刘达信.CT导向下^(125)I粒子植入治疗肺转移瘤[J].中华放射学杂志,2004,38(9):906-909. 被引量:87
  • 2黄振国,张雪哲,王武,洛小林,王继英.CT导引下^(125)I粒子植入在治疗恶性肿瘤中的应用[J].中华放射学杂志,2004,38(9):921-925. 被引量:135
  • 3Fernando HC,De Hoyos A,Landreneau RJ,et al.Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates.J Thorac Cardiovasc Surg,2005,129:639-644.
  • 4Broderick JP,Brott TG,Duldner JE,et al.Volume of intracerebral hemorrhage.A powerful and easy-to-use predictor of 30-day mortality.Stroke,1993,24:987-993.
  • 5Sacks D,Marinelli DL,Martin LG,et al.Reporting standards for clinical evaluation of new peripheral arterial revasularization devices.J Vasc Interv Radiol,2003,14(9 Pt 2):S395-404.
  • 6Cengiz M,G(ǘ)alli S,Selek U,et al.Effect of bladder distension on dose distribution of intracavitary brachytherapy for cervical cancer:three-dimensional computed tomography plan evaluation.Int J Radiat Oncol Biol Phys,2008,70:464-468.

二级参考文献19

  • 1Hakenberg OW , Wirth MP, Hermann T ,et al. Recommendations for the treatment of localized prostate cancer by permanent interstitial brachytherapy(Review).Urol Int,2003,70:15-20.
  • 2Dupuy DE, Zagoria RJ, Akerley W, et al. Percutaneous radiofrequency ablation of malignancies in the lung.AJR, 2000, 174:57-59.
  • 3Zelefsky MJ, Hollister T, Raben A, et al. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys,2000,47:1261-1266.
  • 4Willins J, Wallner K. CT-based dosimetry for transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys,1997,39:347-353.
  • 5Molloy JA, Williams MB. Treatment planning considerations and quality assurance for CT-guided transischiorectal implantation of the prostate. Med Phys,1999,26:1943-1951.
  • 6Martinez-Monge R, Nag S, Nieroda CA, et al. Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver. Cancer,1999,85:1218-1225.
  • 7Vikram B, Mishra S.Permanent iodine-125 implants in postoperative radiotherapy for head and neck cancer with positive surgical margins. Head Neck,1994,16:155-157.
  • 8Kumar PP, Patil AA, Leibrock LG,et al. Continuous low dose rate brachytherapy with high activity iodine-125 seeds in the management of meningiomas. Int J Radiat Oncol Biol Phys,1993,25:325-328.
  • 9Lee DJ, Liberman FZ, Park RI, et al. Intraoperative I-125 seed implantation for extensive recurrent head and neck carcinomas. Radiology,1991,178:879-882.
  • 10Heelan RT, Hilaris BS, Anderson LL, et al. Lung tumors: percutaneous implantation of I-125 sources with CT treatment planning. Radiology, 1987,164:735-740.

共引文献213

同被引文献111

引证文献17

二级引证文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部